Accel Diagnostics
A CLIA high-complexity clinical laboratory and developer/manufacturer of disposable, microfluidic point-of-care blood assays and molecular PCR testing. Offers walk-in and appointment-based clinical testing (COVID-19 antigen/PCR/antibody, molecular pathogen panels, drug screens, wellness panels) and research-use disposable assay cards with smartphone-enabled result capture and encrypted cloud storage. Operates clinical research under IRB and provides rapid same-day or expedited turnaround workflows.
Industries
Nr. of Employees
small (1-50)
Accel Diagnostics
6009 Richmond Ave., Suite #130, Houston TX 77057
Products
Disposable DNA quantitation assay card (research use)
Single-use microfluidic assay for rapid quantitation of double-stranded DNA and PCR products with assay range 2–150 ng/µL, LOD ~2–5 ng/µL, CV ~10%, and 1–2 µL sample volume.
Disposable IgG quantitation assay card (research use)
Mix-and-read disposable assay for rapid quantitation of mouse IgG in cell culture supernatants and other matrices, assay range 2–150 ng/µL, LOD 2–5 ng/µL, CV ~10%, sample volume 1–2 µL.
Disposable smartphone-readable quantitative antibody test (research use / POC development)
Single-use, readerless disposable card intended to provide quantitative antibody titers from a few drops of blood with smartphone readout for trend monitoring and remote clinician review (not FDA-cleared for all uses).
Disposable DNA quantitation assay card (research use)
Single-use microfluidic assay for rapid quantitation of double-stranded DNA and PCR products with assay range 2–150 ng/µL, LOD ~2–5 ng/µL, CV ~10%, and 1–2 µL sample volume.
Disposable IgG quantitation assay card (research use)
Mix-and-read disposable assay for rapid quantitation of mouse IgG in cell culture supernatants and other matrices, assay range 2–150 ng/µL, LOD 2–5 ng/µL, CV ~10%, sample volume 1–2 µL.
Disposable smartphone-readable quantitative antibody test (research use / POC development)
Single-use, readerless disposable card intended to provide quantitative antibody titers from a few drops of blood with smartphone readout for trend monitoring and remote clinician review (not FDA-cleared for all uses).
Services
On-site patient testing services including COVID-19 antigen/PCR/antibody, influenza testing, STD panels, wellness panels (CBC, metabolic, lipid, thyroid), Quantiferon-TB, and other routine clinical tests.
Multiplex PCR panels for urinary tract infection, wound infection, fungal infection, monkeypox and other pathogens with antibiotic resistance marker reporting and same-day result delivery.
Urine-based multi-panel drug screening (5-, 10-, 14-panel) for individual, employment, and DOT compliance, with confirmatory testing workflow for presumptive positives.
Recruitment and sample collection for IRB-approved studies (example: antibody level kinetics after vaccination) with PI oversight and participant compensation.
On-site patient testing services including COVID-19 antigen/PCR/antibody, influenza testing, STD panels, wellness panels (CBC, metabolic, lipid, thyroid), Quantiferon-TB, and other routine clinical tests.
Multiplex PCR panels for urinary tract infection, wound infection, fungal infection, monkeypox and other pathogens with antibiotic resistance marker reporting and same-day result delivery.
Urine-based multi-panel drug screening (5-, 10-, 14-panel) for individual, employment, and DOT compliance, with confirmatory testing workflow for presumptive positives.
Recruitment and sample collection for IRB-approved studies (example: antibody level kinetics after vaccination) with PI oversight and participant compensation.
Expertise Areas
- Point-of-care diagnostics
- Microfluidic assay development
- Molecular PCR panels for infectious disease
- Quantitative serology and biomarker assays
Key Technologies
- Disposable microfluidic assay chips
- Magnetic bead aggregation detection
- Polymerase Chain Reaction (PCR)
- Quantitative immunoassays
News & Updates
Study recruiting subjects to measure antibody levels following vaccination or prior infection; PI contact provided and participants compensated.
Study recruiting subjects to measure antibody levels following vaccination or prior infection; PI contact provided and participants compensated.